Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial.
Carles J, Alonso-Gordoa T, Mellado B, Méndez-Vidal MJ, Vázquez S, González-Del-Alba A, Piulats JM, Borrega P, Gallardo E, Morales-Barrera R, Paredes P, Reig O, Garcías de España C, Collado R, Bonfill T, Suárez C, Sampayo-Cordero M, Malfettone A, Garde J. Carles J, et al. Among authors: paredes p. Eur J Cancer. 2022 Sep;173:317-326. doi: 10.1016/j.ejca.2022.06.057. Epub 2022 Aug 16. Eur J Cancer. 2022. PMID: 35981452 Free article. Clinical Trial.
Diagnostic utility and therapeutic impact of PET/CT [18F]F-Fluoromethylcholine -Choline in the biochemical recurrence of prostate cancer.
Sánchez N, Valduvieco I, Ribal MJ, Campos F, Casas F, Nicolau C, Salvador R, Mellado B, Jorcano S, Fuster D, Paredes P. Sánchez N, et al. Among authors: paredes p. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Sep-Oct;39(5):284-291. doi: 10.1016/j.remn.2020.03.010. Epub 2020 May 25. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020. PMID: 32467000 English, Spanish.
Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [18F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125.
Glickman A, Paredes P, Carreras-Diéguez N, Niñerola-Baizán A, Gaba L, Pahisa J, Fusté P, Del Pino M, Díaz-Feijóo B, González-Bosquet E, Agustí N, Sánchez-Izquierdo N, Fuster D, Perissinotti A, Romero I, Fernández-Galán E, Carrasco JL, Gil-Ibáñez B, Torné A. Glickman A, et al. Among authors: paredes p. Eur Radiol. 2022 Apr;32(4):2200-2208. doi: 10.1007/s00330-021-08305-x. Epub 2021 Sep 29. Eur Radiol. 2022. PMID: 34586465
Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement.
Agustí N, Vidal-Sicart S, Paredes P, Celada-Castro C, Migliorelli F, Glickman A, Marina T, Fusté P, Carreras-Dieguez N, Saco A, Díaz-Feijóo B, Torné A. Agustí N, et al. Among authors: paredes p. Gynecol Oncol. 2023 Dec;179:145-151. doi: 10.1016/j.ygyno.2023.11.007. Epub 2023 Nov 18. Gynecol Oncol. 2023. PMID: 37980769 Clinical Trial.
143 results